A zebrafish model of chordoma initiated by notochord-driven expression of HRASV12
暂无分享,去创建一个
D. Haber | M. Selig | R. Peterson | I. Drummond | G. Nielsen | A. Burger | A. Vasilyev | Ritu Tomar | Alexa Burger
[1] B. Nahed,et al. Chordoma: current concepts, management, and future directions. , 2012, The Lancet. Oncology.
[2] F. Bertucci,et al. Efficacy of epidermal growth factor receptor targeting in advanced chordoma: case report and literature review , 2011, BMC Cancer.
[3] R. Sciot,et al. Frequent activation of EGFR in advanced chordomas , 2011, Clinical Sarcoma Research.
[4] Z. Gong,et al. A high level of liver-specific expression of oncogenic KrasV12 drives robust liver tumorigenesis in transgenic zebrafish , 2011, Disease Models & Mechanisms.
[5] Julie M. Batten,et al. Recurrent Chromosomal Copy Number Alterations in Sporadic Chordomas , 2011, PloS one.
[6] James M. Harris,et al. Prostaglandin E2 enhances human cord blood stem cell xenotransplants and shows long-term safety in preclinical nonhuman primate transplant models. , 2011, Cell stem cell.
[7] Charles Y. Lin,et al. DHODH modulates transcriptional elongation in the neural crest and melanoma , 2011, Nature.
[8] T. Jacques,et al. Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional‐based study , 2011, The Journal of pathology.
[9] A. Shalaby,et al. The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target , 2011, The Journal of pathology.
[10] Martin Distel,et al. Kita Driven Expression of Oncogenic HRAS Leads to Early Onset and Highly Penetrant Melanoma in Zebrafish , 2010, PloS one.
[11] P. Casali,et al. Response to imatinib plus sirolimus in advanced chordoma. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.
[12] A. Goldstein,et al. T (brachyury) gene duplication confers major susceptibility to familial chordoma , 2009, Nature Genetics.
[13] P. Rutkowski,et al. Epidermal growth factor receptor (EGFR) status in chordoma. , 2009, Polish journal of pathology : official journal of the Polish Society of Pathologists.
[14] M. Wullimann,et al. Optimized Gal4 genetics for permanent gene expression mapping in zebrafish , 2009, Proceedings of the National Academy of Sciences.
[15] C. Antonescu,et al. Combination of PI3K/mTOR inhibition demonstrates efficacy in human chordoma. , 2009, Anticancer research.
[16] I. Gout,et al. Potential therapeutic targets for chordoma: PI3K/AKT/TSC1/TSC2/mTOR pathway , 2009, British Journal of Cancer.
[17] G. Nielsen,et al. Aberrant Hyperactivation of Akt and Mammalian Target of Rapamycin Complex 1 Signaling in Sporadic Chordomas , 2009, Clinical Cancer Research.
[18] G. Jönsson,et al. Frequent deletion of the CDKN2A locus in chordoma: analysis of chromosomal imbalances using array comparative genomic hybridisation , 2007, British Journal of Cancer.
[19] L. Helman,et al. The biology behind mTOR inhibition in sarcoma. , 2007, The Oncologist.
[20] L. Zon,et al. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis , 2007, Nature.
[21] Alan N. Mayer,et al. Target of rapamycin (TOR) signaling controls epithelial morphogenesis in the vertebrate intestine. , 2007, Developmental biology.
[22] L. Cantley,et al. Ras, PI(3)K and mTOR signalling controls tumour cell growth , 2006, Nature.
[23] A. Samii,et al. Alterations of G1‐S checkpoint in chordoma , 2005, Cancer.
[24] A. Psyrri,et al. Differential expression of epidermal growth factor receptor, c-Met, and HER2/neu in chordoma compared with 17 other malignancies. , 2005, Archives of otolaryngology--head & neck surgery.
[25] A. Stemmer-Rachamimov,et al. Sacrococcygeal chordomas in patients with tuberous sclerosis complex show somatic loss of TSC1 or TSC2 , 2004, Genes, chromosomes & cancer.
[26] P. Meltzer,et al. Mechanisms of sarcoma development , 2003, Nature Reviews Cancer.
[27] R. Pallini,et al. Chordoma of the skull base: predictors of tumor recurrence. , 2003, Journal of neurosurgery.
[28] B. Hemmings,et al. Inhibition of protein kinase B/Akt. implications for cancer therapy. , 2002, Pharmacology & therapeutics.
[29] S. Du,et al. Zebrafish tiggy‐winkle hedgehog promoter directs notochord and floor plate green fluorescence protein expression in transgenic zebrafish embryos , 2001, Developmental dynamics : an official publication of the American Association of Anatomists.
[30] D. Wolfe,et al. Loss of heterozygosity in the retinoblastoma tumor suppressor gene in skull base chordomas and chondrosarcomas. , 1997, Surgical neurology.
[31] I. Drummond,et al. Live imaging kidney development in zebrafish. , 2012, Methods in molecular biology.
[32] L. Zon,et al. Advanced zebrafish transgenesis with Tol2 and application for Cre/lox recombination experiments. , 2011, Methods in cell biology.
[33] J. Davison,et al. Characterization of Kras-mediated pancreatic tumorigenesis in zebrafish. , 2008, Methods in enzymology.
[34] M. Westerfield. The zebrafish book : a guide for the laboratory use of zebrafish (Danio rerio) , 1995 .